International Manufacturing Presence Crosstex International operates eight manufacturing and distribution facilities worldwide, including five in the United States, providing a strong local and global supply chain. This extensive manufacturing infrastructure supports timely delivery and potential scalability for new healthcare product lines or sterilization innovations.

Focus on Infection Control As a leading producer of infection prevention products such as sterilization pouches, face masks, and antimicrobial gels, Crosstex’s portfolio is crucial for healthcare facilities prioritizing infection control. There are opportunities to expand sales with hospitals seeking comprehensive infection prevention solutions.

Recent Product Innovation The launch of new products like the Axess Mask indicates Crosstex’s commitment to innovation in healthcare PPE. This focus on lightweight, comfortable masks opens avenues for partnerships with hospitals and clinics looking to upgrade their protective equipment with high-quality, comfortable options.

Market Footprint and Acquisition Crosstex’s acquisition of SPSmedical enhances its product range and market reach within healthcare supply chains. There is potential to leverage this expanded footprint to introduce complementary products or bundled solutions to existing clients.

Industry and Competitor Landscape Operating in a competitive market with companies like Hospira and Halyard Health, Crosstex can differentiate through its US manufacturing base, product innovation, and focus on infection prevention—key selling points for healthcare providers prioritizing quality and reliability.